AVXL logo

Anavex Life Sciences (AVXL) EBITDA

Annual EBITDA

-$43.00 M
+$3.53 M+7.59%

September 30, 2024

Summary

Performance

1-Year Change

+7.59%

3-Year Change

-14.24%

5-Year Change

-49.27%

15-Year Change

-176.73%

AVXL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.8%
AVXL annual EBITDA is higher than 35.8% of companies in Healthcare sector

High & Low

All-time High

-$14.50 K

3-Year Low

-$47.62 M

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
AVXL previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
AVXL next annual earnings announcement has not yet been scheduled

OtherAVXLprofitabilitymetrics:

Annual Revenue

-
AVXL annual revenue value is unknown

Annual Net Income

-$43.00 M
AVXL annual net profit is -$43.00 million

Annual EBIT

-$43.00 M
AVXL annual earnings before interest & taxes is -$43.00 million

Annual EPS

-$0.52
AVXL annual earnings per share is -$0.52

Quarterly EBITDA

-$11.74 M
+$537.00 K+4.37%

September 30, 2024

Summary

Performance

3-Month Change

+4.37%

1-Year Change

+4.37%

3-Year Change

-47.8%

5-Year Change

-47.8%

AVXL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.56%
AVXL quarterly EBITDA is higher than 33.56% of companies in Healthcare sector

High & Low

All-time High

$362.10 K
AVXL quarterly EBITDA is currently -3343.30% below its historical high of $362.10 thousand

3-Year Low

-$15.36 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AVXL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
AVXL next earnings announcement is scheduled for Feb 7, 2025

OtherAVXLprofitabilitymetrics:

Quarterly Revenue

-
AVXL quarterly revenue value is unknown

Quarterly Net Income

-$11.62 M
AVXL quarterly net profit is -$11.62 million

Quarterly EBIT

-$11.74 M
AVXL quarterly earnings before interest & taxes is -$11.74 million

Quarterly EPS

-$0.14
AVXL quarterly earnings per share is -$0.14

TTM EBITDA

-$45.76 M
-$1.53 M-3.47%

September 30, 2024

Summary

Performance

3-Month Change

-3.47%

1-Year Change

-3.47%

3-Year Change

-21.57%

5-Year Change

-21.57%

AVXL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.05%
AVXL TTM EBITDA is higher than 33.05% of companies in Healthcare sector

High & Low

All-time High

-$4100.00

3-Year Low

-$53.81 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AVXL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 7, 2025
AVXL next earnings announcement is scheduled for Feb 7, 2025

OtherAVXLprofitabilitymetrics:

TTM Revenue

-
AVXL TTM revenue value is unknown

TTM Net Income

-$43.00 M
AVXL TTM net profit is -$43.00 million

TTM EBIT

-$45.76 M
AVXL TTM earnings before interest & taxes is -$45.76 million

TTM EPS

-$0.52
AVXL TTM earnings per share is -$0.52

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$43.00 M
AVXL annual EBITDA is -$43.00 million

Annual Net Income

-$43.00 M
AVXL annual net profit is -$43.00 million

Annual Interest Expense

$0.00
AVXL annual interest expense is $0.00

Annual Income Tax

$0.00
AVXL annual income tax is $0.00

Annual D&A

-
AVXL annual depreciation & amortization value is unknown

AVXL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.6%+4.4%-3.5%
3 y3 years-14.2%-47.8%-21.6%
5 y5 years-49.3%-47.8%-21.6%

AVXL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-14.2%+9.7%-15.0%+23.5%-14.5%+15.0%
5 y5-year-49.3%+9.7%-56.4%+23.5%-59.6%+15.0%
alltimeall time<-9999.0%+9.7%-3343.3%+23.5%<-9999.0%+15.0%

Anavex Life Sciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-$43.00 M(-7.6%)
-$11.74 M(-4.4%)
-$45.76 M(+3.5%)
Jun 2024
-
-$12.28 M(+17.6%)
-$44.23 M(+2.4%)
Mar 2024
-
-$10.44 M(-7.5%)
-$43.18 M(-3.7%)
Dec 2023
-
-$11.29 M(+10.6%)
-$44.84 M(-8.3%)
Sep 2023
-$46.53 M(-2.3%)
-$10.21 M(-9.2%)
-$48.90 M(-7.3%)
Jun 2023
-
-$11.24 M(-7.1%)
-$52.77 M(-1.9%)
Mar 2023
-
-$12.09 M(-21.3%)
-$53.81 M(+1.1%)
Dec 2022
-
-$15.36 M(+9.1%)
-$53.24 M(+7.3%)
Sep 2022
-$47.62 M(+26.5%)
-$14.08 M(+14.7%)
-$49.60 M(+14.1%)
Jun 2022
-
-$12.28 M(+6.6%)
-$43.47 M(+2.2%)
Mar 2022
-
-$11.52 M(-1.7%)
-$42.54 M(+6.4%)
Dec 2021
-
-$11.72 M(+47.5%)
-$39.97 M(+6.2%)
Sep 2021
-$37.64 M(+21.7%)
-$7.95 M(-30.0%)
-$37.64 M(+1.2%)
Jun 2021
-
-$11.36 M(+27.0%)
-$37.20 M(+9.6%)
Mar 2021
-
-$8.94 M(-4.8%)
-$33.95 M(+3.8%)
Dec 2020
-
-$9.40 M(+25.2%)
-$32.71 M(+5.7%)
Sep 2020
-$30.94 M(+7.4%)
-$7.51 M(-7.4%)
-$30.94 M(+4.2%)
Jun 2020
-
-$8.11 M(+5.3%)
-$29.70 M(+3.6%)
Mar 2020
-
-$7.70 M(+0.9%)
-$28.67 M(-1.3%)
Dec 2019
-
-$7.63 M(+21.6%)
-$29.03 M(+0.8%)
Sep 2019
-$28.81 M(+50.2%)
-$6.27 M(-11.3%)
-$28.81 M(+1.6%)
Jun 2019
-
-$7.07 M(-12.3%)
-$28.35 M(+9.8%)
Mar 2019
-
-$8.07 M(+9.0%)
-$25.82 M(+14.8%)
Dec 2018
-
-$7.40 M(+27.3%)
-$22.49 M(+17.2%)
Sep 2018
-$19.18 M(+23.5%)
-$5.81 M(+28.0%)
-$19.18 M(+3.4%)
Jun 2018
-
-$4.54 M(-4.0%)
-$18.55 M(+5.1%)
Mar 2018
-
-$4.73 M(+15.7%)
-$17.64 M(+6.9%)
Dec 2017
-
-$4.09 M(-21.0%)
-$16.50 M(+6.2%)
Sep 2017
-$15.54 M(+0.6%)
-$5.18 M(+42.4%)
-$15.54 M(-8.1%)
Jun 2017
-
-$3.64 M(+1.2%)
-$16.92 M(+9.0%)
Mar 2017
-
-$3.59 M(+14.6%)
-$15.53 M(+10.2%)
Dec 2016
-
-$3.13 M(-52.2%)
-$14.09 M(-5.3%)
Sep 2016
-$15.45 M(+28.3%)
-$6.55 M(+191.9%)
-$14.88 M(-13.6%)
Jun 2016
-
-$2.25 M(+4.3%)
-$17.21 M(+4.4%)
Mar 2016
-
-$2.15 M(-45.1%)
-$16.48 M(+8.5%)
Dec 2015
-
-$3.92 M(-55.9%)
-$15.19 M(+26.8%)
Sep 2015
-$12.04 M(+305.5%)
-$8.89 M(+488.0%)
-$11.97 M(+172.4%)
Jun 2015
-
-$1.51 M(+76.3%)
-$4.40 M(+13.2%)
Mar 2015
-
-$858.10 K(+20.9%)
-$3.88 M(-3.8%)
Dec 2014
-
-$709.50 K(-46.1%)
-$4.04 M(+36.1%)
DateAnnualQuarterlyTTM
Sep 2014
-$2.97 M(-18.6%)
-$1.32 M(+31.6%)
-$2.97 M(-35.9%)
Jun 2014
-
-$1.00 M(-1.3%)
-$4.63 M(+22.9%)
Mar 2014
-
-$1.01 M(-379.9%)
-$3.77 M(+32.5%)
Dec 2013
-
$362.10 K(-112.2%)
-$2.84 M(-22.1%)
Sep 2013
-$3.65 M(-54.8%)
-$2.98 M(+2072.7%)
-$3.65 M(+172.6%)
Jun 2013
-
-$137.10 K(+53.4%)
-$1.34 M(-76.5%)
Mar 2013
-
-$89.40 K(-79.8%)
-$5.69 M(-11.3%)
Dec 2012
-
-$442.80 K(-33.8%)
-$6.42 M(-20.5%)
Sep 2012
-$8.06 M(+30.7%)
-$669.10 K(-85.1%)
-$8.07 M(+4.7%)
Jun 2012
-
-$4.49 M(+450.7%)
-$7.71 M(+60.9%)
Mar 2012
-
-$815.10 K(-61.1%)
-$4.79 M(-19.4%)
Dec 2011
-
-$2.09 M(+579.5%)
-$5.94 M(+13.9%)
Sep 2011
-$6.17 M(+9.3%)
-$308.10 K(-80.4%)
-$5.21 M(-24.1%)
Jun 2011
-
-$1.57 M(-20.1%)
-$6.87 M(+4.1%)
Mar 2011
-
-$1.97 M(+43.9%)
-$6.60 M(+4.5%)
Dec 2010
-
-$1.37 M(-30.4%)
-$6.31 M(+17.1%)
Sep 2010
-$5.65 M(+19.3%)
-$1.96 M(+50.7%)
-$5.39 M(+3.1%)
Jun 2010
-
-$1.30 M(-22.4%)
-$5.23 M(+0.9%)
Mar 2010
-
-$1.68 M(+279.2%)
-$5.18 M(+21.3%)
Dec 2009
-
-$442.90 K(-75.4%)
-$4.27 M(-9.8%)
Sep 2009
-$4.73 M(-10.2%)
-$1.80 M(+43.3%)
-$4.73 M(-15.8%)
Jun 2009
-
-$1.26 M(+63.2%)
-$5.62 M(+5.0%)
Mar 2009
-
-$769.90 K(-15.0%)
-$5.36 M(+1.9%)
Dec 2008
-
-$905.80 K(-66.3%)
-$5.26 M(-1.5%)
Sep 2008
-$5.27 M(+234.0%)
-$2.69 M(+171.7%)
-$5.34 M(+40.9%)
Jun 2008
-
-$990.20 K(+47.4%)
-$3.79 M(+24.0%)
Mar 2008
-
-$671.70 K(-32.0%)
-$3.06 M(+19.7%)
Dec 2007
-
-$987.50 K(-13.4%)
-$2.55 M(+61.8%)
Sep 2007
-$1.58 M(+6063.7%)
-$1.14 M(+346.3%)
-$1.58 M(+256.5%)
Jun 2007
-
-$255.60 K(+51.4%)
-$442.50 K(+129.8%)
Mar 2007
-
-$168.80 K(+1272.4%)
-$192.60 K(+575.8%)
Dec 2006
-
-$12.30 K(+112.1%)
-$28.50 K(+11.3%)
Sep 2006
-$25.60 K(-72.1%)
-$5800.00(+1.8%)
-$25.60 K(-58.6%)
Jun 2006
-
-$5700.00(+21.3%)
-$61.80 K(-39.3%)
Mar 2006
-
-$4700.00(-50.0%)
-$101.80 K(-28.7%)
Dec 2005
-
-$9400.00(-77.6%)
-$142.80 K(+3.9%)
Sep 2005
-$91.70 K(+532.4%)
-$42.00 K(-8.1%)
-$137.50 K(+44.0%)
Jun 2005
-
-$45.70 K(0.0%)
-$95.50 K(+91.8%)
Mar 2005
-
-$45.70 K(+1014.6%)
-$49.80 K(+1114.6%)
Dec 2004
-
-$4100.00
-$4100.00
Sep 2004
-$14.50 K
-
-

FAQ

  • What is Anavex Life Sciences annual EBITDA?
  • What is the all time high annual EBITDA for Anavex Life Sciences?
  • What is Anavex Life Sciences annual EBITDA year-on-year change?
  • What is Anavex Life Sciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Anavex Life Sciences?
  • What is Anavex Life Sciences quarterly EBITDA year-on-year change?
  • What is Anavex Life Sciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Anavex Life Sciences?
  • What is Anavex Life Sciences TTM EBITDA year-on-year change?

What is Anavex Life Sciences annual EBITDA?

The current annual EBITDA of AVXL is -$43.00 M

What is the all time high annual EBITDA for Anavex Life Sciences?

Anavex Life Sciences all-time high annual EBITDA is -$14.50 K

What is Anavex Life Sciences annual EBITDA year-on-year change?

Over the past year, AVXL annual EBITDA has changed by +$3.53 M (+7.59%)

What is Anavex Life Sciences quarterly EBITDA?

The current quarterly EBITDA of AVXL is -$11.74 M

What is the all time high quarterly EBITDA for Anavex Life Sciences?

Anavex Life Sciences all-time high quarterly EBITDA is $362.10 K

What is Anavex Life Sciences quarterly EBITDA year-on-year change?

Over the past year, AVXL quarterly EBITDA has changed by +$537.00 K (+4.37%)

What is Anavex Life Sciences TTM EBITDA?

The current TTM EBITDA of AVXL is -$45.76 M

What is the all time high TTM EBITDA for Anavex Life Sciences?

Anavex Life Sciences all-time high TTM EBITDA is -$4100.00

What is Anavex Life Sciences TTM EBITDA year-on-year change?

Over the past year, AVXL TTM EBITDA has changed by -$1.53 M (-3.47%)